Declaration: Novel SLC3A1 mutation in a cystinuria patient with xanthine stones: a case report
Декларация: Новый вариант мутации SLC3A1 у пациента с цистинурией и ксантиновыми камнями: клинический случай
2023-07-31
SCID: 54.1/38qh2f7x
Discuss with AI
SLC3A1 c.1113 C>A (p.Tyr371*)cystinuriahomozygous nonsense mutationnext-generation sequencingxanthine stones
Figures from the paper
Abstract (AI)
BACKGROUND: Cystinuria and xanthinuria are both rare genetic diseases involving urinary calculi. However, cases combining these two disorders have not yet been reported. CASE PRESENTATION: In this study, we report a case of cystinuria with xanthine stones and hyperuricemia. The 23-year-old male patient was diagnosed with kidney and ureteral stones, solitary functioning kidney and hyperuricemia after admission to the hospital. The stones were removed by surgery and found to be composed of xanthine. CONCLUSION: Genetic testing by next-generation sequencing technology showed that the patient carried the homozygous nonsense mutation c.1113 C> A (p.Tyr371*) in the SLC3A1 gene, which was judged to be a functionally pathogenic variant. Sanger sequencing revealed that the patient's parents carried this heterozygous mutation, which is a pathogenic variant that can cause cystinuria. The 24-h urine metabolism analysis showed that the cystine content was 644 mg (<320 mg/24 h), indicating that the patient had cystinuria, consistent with the genetic test results. This case shows that cystinuria and xanthine stones can occur simultaneously, and provides evidence of a possible connection between the two conditions. Furthermore, our findings demonstrate the potential value of genetic testing using next-generation sequencing to effectively assist in the clinical diagnosis and treatment of patients with urinary calculi.
Key Findings
1
24-hour urine showed elevated cystine (644 mg/24 h, normal <320 mg/24 h), confirming biochemical diagnosis of cystinuria concordant with genetics.
2
Identification of a homozygous nonsense mutation c.1113 C>A (p.Tyr371*) in SLC3A1 judged functionally pathogenic by next-generation sequencing.
3
Next-generation sequencing genetic testing can effectively assist clinical diagnosis and treatment decisions for patients with urinary calculi.
4
Parents were heterozygous carriers of the same SLC3A1 pathogenic variant, consistent with recessive inheritance of cystinuria.
5
This case documents simultaneous occurrence of cystinuria and xanthine stones, suggesting a possible connection between the two conditions.
Research Object
Patient with cystinuria and xanthine kidney stones carrying a homozygous nonsense SLC3A1 c.1113 C>A (p.Tyr371*) mutation
Research Subject
Association between the novel SLC3A1 mutation and the patient's cystinuria and concurrent xanthine stones, and the diagnostic utility of next-generation sequencing genetic testing for urinary calculi
Publication Details
Publication Date
2023-07-31
Journal
Publisher
ISSN
Cited by
1
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest